UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

Hindustan Unilever (HUL)- the country's leading FMCG player will come up with its Q2 earnings on October 23, 2024 (Wednesday) ...

Nigeria’s manufacturing sector is under siege. The cruel combination of high energy costs, foreign exchange scarcity, rising ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

SBI Securities has recommended buying shares of Coal India, Macrotech Developers, Bharti Hexacom, Nippon Life India, Escorts ...

Global pharma major Lupin Limited (Lupin) announced the appointment of Claus Jepsen as president, global specialty. He brings ...

Necrobiosis Lipoidica Diabeticorum MarketThe global Necrobiosis Lipoidica Diabeticorum (NLD) market is expected to be worth USD 4.5 billion in 2023 and USD 8.06 billion by 2033, with a CAGR of 6% from ...

NEW YORK, Oct. 21, 2024 /PRNewswire/ -- Report with the AI impact on market trends- The global sexually transmitted disease ...

In patients with uncomplicated UTI, the presence of positive vs negative ESBL uropathogens differed by symptom severity, race, and age plus recurrent UTI history.